Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis-Reference-Cited by-同舟云学术

Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis

Published:2018-01-12 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Grace Angeline G¹,Mittal Abhenil²,Jain Siddharth²,Tripathy Jaya P³,Satyanarayana Srinath³,Tharyan Prathap⁴,Kirubakaran Richard⁴

Affiliation:

1. National Institute for Research in Tuberculosis; Department of Clinical Research; No 1 Mayor Sathyamoorthy Road Chetpet Chennai India 600031

2. All India Institute of Medical Sciences; Department of Internal Medicine; New Delhi India

3. International Union Against Tuberculosis and Lung Disease (The Union), South-East Asia Regional Office; New Delhi India

4. Christian Medical College; Cochrane South Asia, Prof. BV Moses Center for Evidence-Informed Health Care and Health Policy; Carman Block II Floor CMC Campus, Bagayam Vellore Tamil Nadu India 632002

Publisher

Wiley

Subject

Pharmacology (medical)

Reference41 articles.

1. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis;Andries;Science,2005

2. Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial;Conde;Lancet,2009

3. New anti-tuberculosis drugs and regimens: 2015 update;D'Ambrosio;ERJ Open Research,2015

4. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis;Dawson;Lancet,2015

5. Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance;Diacon;Antimicrobial Agents and Chemotherapy,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular bases of the interaction of <i>Mycobacteria tuberculosis complex</i> and anti-tuberculosis drugs: Current state of the problem and its epidemiological significance;Epidemiology and Infectious Diseases;2023-06-01

2. Adapting Clofazimine for Treatment of Cutaneous Tuberculosis by Using Self-Double-Emulsifying Drug Delivery Systems;Antibiotics;2022-06-15

3. Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis;Clinical Microbiology Reviews;2020-12-16

4. Targeted Delivery of Antibiotics Using Microparticles to Combat Multidrug-Resistant Tuberculosis;Antibacterial Drug Discovery to Combat MDR;2019